43.67
+1.61%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Prestige Consumer Healthcare
From its filings with the US Securities and Exchange Commission
Prestige Consumer Healthcare is based in Tarrytown, New York. Its shares trade on NYSE under the ticker PBH. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 March 2026, it reported revenue of $1.09bn and net income of $190.3m. At that date it held total assets of $3.49bn and shareholders' equity of $1.89bn.
We have grown our product portfolio both organically and through acquisitions. We develop our existing brands by investing in new product lines, brand extensions and strong advertising support. Acquisitions of consumer health and personal care brands have also been an important part of our growth strategy. We pursue this growth following an acquisition through spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations and innovative development of brand extensions.
We conduct our operations in two reportable segments: North American OTC Healthcare and International OTC Healthcare.
Our major brands, set forth in the table below, have strong levels of consumer awareness and retail distribution across all major channels. These brands accounted for approximately 83.5%, 83.0% and 83.3% of our total revenues for 2026, 2025, and 2024, respectively.
(2)“Market segment” is defined by us and is either a standard IRI category or a segment within a standard IRI category and is based on our product offerings and the categories in which we compete.
Quoted from its 10-K, filed 14 May 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 10 Feb 2005
- Employees
- 890
- Website
- prestigebrands.com ↗
- Head office
- 660 WHITE PLAINS RD., TARRYTOWN, NY, 10591
- Classification
- Pharmaceutical Preparations
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Ronald LombardiChairman of the Board, President, Chief Executive Officer, since 2010$6.2m
- Ms. Christine SaccoChief Financial Officer, Chief Operating Officer$3.9m
- Mr. Adel MekhailExecutive Vice President - Marketing & Sales$1.4m
- Mr. William P'PoolSenior Vice President, General Counsel, Corporate Secretary$1.4m
- Mr. Jeffrey ZerilloSenior Vice President - Operations$901,252
- Mr. John ByomLead Independent Director$275,022
- Dr. Celeste ClarkIndependent Director$260,022
- Mr. James D'AreccaIndependent Director$265,022
- Ms. Sheila HopkinsIndependent Director$245,022
- Mr. John KellyIndependent Director$227,113
- Ms. Dawn ZierIndependent Director$265,022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 63
- Environment
- 53
- Social
- 76
- Governance
- 59
- Direct emissions (scope 1)
- 1,438.38 t
- Energy emissions (scope 2)
- 7,141.31 t
- Value chain emissions (scope 3)
- 141,347.58 t
- Women in the workforce
- 53%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Prestige Consumer Healthcare Inc has several strengths that contribute to its competitive advantage in the market. Firstly, the company has a diverse portfolio of consumer healthcare products, including over-the-counter medications, dietary supplements, and personal care items. This wide range of offerings helps to cater to a broad customer base and provides multiple revenue streams.
- Secondly, Prestige Consumer Healthcare Inc has a strong brand presence, with well-established names like BC Powder, Efferdent, and Chloraseptic. These trusted brands enjoy high brand recognition and customer loyalty, giving the company a significant advantage over its competitors.
Weaknesses
- Despite its strengths, Prestige Consumer Healthcare Inc also faces certain weaknesses that could impede its growth and profitability. Firstly, the company heavily relies on a few key products for a significant portion of its revenue. This overreliance on a limited number of products increases the risk of revenue fluctuations if any of these products face market challenges or regulatory issues.
- Additionally, Prestige Consumer Healthcare Inc operates in a highly competitive industry with various well-established players. Competing against larger and more resourceful competitors could pose challenges for the company, especially in terms of market share and pricing power.
Opportunities
- The consumer healthcare industry offers several opportunities for Prestige Consumer Healthcare Inc to further expand its business. Firstly, the growing focus on health and wellness presents an opportunity for the company to develop and market new products that cater to this trend. This could include innovative dietary supplements, organic personal care items, or specialized medications.
- Moreover, Prestige Consumer Healthcare Inc can leverage its existing strong brand presence to enter new markets or expand its distribution channels. This could involve partnerships with retailers, e-commerce platforms, or exploring international markets.
Threats
- Despite the existing opportunities, Prestige Consumer Healthcare Inc faces certain threats that could pose challenges to its success. Firstly, regulatory changes or scrutiny could impact the company's ability to manufacture or market certain products, resulting in potential restrictions or increased compliance costs.
- Additionally, sudden shifts in consumer preferences or disruptive technologies could render some of Prestige Consumer Healthcare Inc's products less relevant or obsolete, requiring continuous adaptation and innovation to stay competitive.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.